The Protective Effect of Resveratrol on Concanavalin-A-Induced Acute Hepatic Injury in Mice

Gastroenterology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Zhou, Yingqun ^a   Chen, Kan ^a   He, Lei ^a   Xia, Yujing ^a   Dai, Weiqi ^a   Wang, Fan ^a   Li, Jingjing ^a   Li, Sainan ^a   Liu, Tong ^a   Zheng, Yuanyuan ^a   Wang, Jianrong ^a,b   Lu, Wenxia ^a,b   Yin, Qin ^a,c   Zhou, Yuqing ^a,c   Lu, Jie ^a   Teng, Hongfei ^a   Guo, Chuanyong ^a  

^a TONGJI UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CONCANAVALIN A; INTERLEUKIN 2; INTERLEUKIN 6; PROTEIN PATCHED; RESVERATROL; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEPATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE HEPATITIS; CONCANAVALIN A-INDUCED HEPATITIS; DRUG MECHANISM; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER PROTECTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 84935869839     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2015/506390     Document Type: Article

References (46)

1. A. Bishayee, A. S. Darvesh, T. Politis, and R. McGory, "Resveratrol and liver disease: from bench to bedside and community", Liver International, vol. 30, no. 8, pp. 1103-1114, 2010.
2. P. Muriel and Y. Rivera-Espinoza, "Beneficial drugs for liver diseases", Journal of Applied Toxicology, vol. 28, no. 2, pp. 93-103, 2008.
3. M. Heron, D. L. Hoyert, S. L. Murphy et al., Deaths: Final Data for 2006, National Vital Statistics Report, National Center for Health Statistics, Hyattsville, Md, USA, 2009.
4. American Gastroenterological Association, The Burden of Gastrointestinal Diseases, American Gastroenterological Diseases, American Gastroenterological Association, Bethesda, Md, USA, 2001.
5. S.-W. Hong, K. H. Jung, H.-M. Zheng et al., "The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats", Archives of Pharmacal Research, vol. 33, no. 4, pp. 601-609, 2010.
6. G. Oktem, A. Uysal, O. Oral et al., "Resveratrol attenuates doxorubicin-induced cellular damage by modulating nitric oxide and apoptosis", Experimental and Toxicologic Pathology, vol. 64, no. 5, pp. 471-479, 2012.
7. J. A. Rubiolo, G. Mithieux, and F.V. Vega, "Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes", European Journal of Pharmacology, vol. 591, no. 1-3, pp. 66-72, 2008.
8. M. Maccarrone, T. Lorenzon, P. Guerrieri, and A. F. Agro, "Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity", European Journal of Biochemistry, vol. 265, no. 1, pp. 27-34, 1999.
9. J. Martinez and J. J. Moreno, "Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production", Biochemical Pharmacology, vol. 59, no. 7, pp. 865-870, 2000.
10. S. Shishodia and B. B. Aggarwal, "Resveratrol: a polyphenol for all seasons", in Resveratrolin Health and Disease, B. B. Aggarwal and S. Shishodia, Eds., pp. 1-16, CRC Press, Boca Raton, Fla, USA, 2006.
11. P. Saiko, A. Szakmary, W. Jaeger, and T. Szekeres, "Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?" Mutation Research, vol. 658, no. 1-2, pp. 68-94, 2008.
12. A. Bishayee, "Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials", Cancer Prevention Research, vol. 2, no. 5, pp. 409-418, 2009.
13. C. D. Mann, C. P. Neal, G. Garcea, M. M. Manson, A. R. Dennison, and D. P. Berry, "Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis", European Journal of Cancer Prevention, vol. 18, no. 1, pp. 13-25, 2009.
14. G. Şener, H. Z. Toklu, A. Ö. Şehirli, A. Velioʇlu-Öʇünç, S. Çetinel, and N. Gedik, "Protective effects of resveratrol against acetaminophen-induced toxicity in mice", Hepatology Research, vol. 35, no. 1, pp. 62-68, 2006.
15. A. Kasdallah-Grissa, B. Mornagui, E. Aouani et al., "Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats", Alcohol and Alcoholism, vol. 41, no. 3, pp. 236-239, 2006.
16. E. Chávez, K. Reyes-Gordillo, J. Segovia et al., "Resveratrol prevents fibrosis, NF-κB activation and TGF-β increases induced by chronic CCl4 treatment in rats", Journal of Applied Toxicology, vol. 28, no. 1, pp. 35-43, 2008.
17. P. Vitaglione, B. Ottanelli, S. Milani, F. Morisco, N. Caporaso, and V. Fogliano, "Dietary trans-resveratrol bioavailability and effect on CCl 4-induced liver lipid peroxidation", Journal of Gastroenterology and Hepatology, vol. 24, no. 4, pp. 618-622, 2009.
18. S. V. Fleig, S. S. Choi, L. Yang et al., "Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice", Laboratory Investigation, vol. 87, no. 12, pp. 1227-1239, 2007.
19. J. K. Sicklick, Y.-X. Li, A. Melhem et al., "Hedgehog signaling maintains resident hepatic progenitors throughout life", The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 290, no. 5, pp. G859-G870, 2006.
20. Y. Jung, K. D. Brown, R. P. Witek et al., "Accumulation of Hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans", Gastroenterology, vol. 134, no. 5, pp. 1532-1543, 2008.
21. Y. Jung, S. J. McCall, Y.-X. Li, and A.M. Diehl, "Bileductules and stromal cells express hedgehog ligands and/or hedgehog target genes in primary biliary cirrhosis", Hepatology, vol. 45, no. 5, pp. 1091-1096, 2007.
22. +T lymphocytes", Journal of Immunology, vol. 169, no. 4, pp. 1869-1875, 2002.
23. 4+T cells", Journal of Immunology, vol. 169, no. 10, pp. 5451-5457, 2002.
24. R. P. Witek, L. Yang, R. Liu et al., "Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells", Gastroenterology, vol. 136, no. 1, pp. 320.e2-330.e2, 2009.
25. L. Yang, Y. Wang, H. Mao et al., "Sonic hedgehog is an autocrine viability factor formyofibroblastic hepatic stellate cells", Journal of Hepatology, vol. 48, no. 1, pp. 98-106, 2008.
26. S. S. Choi, A. Omenetti, R. P. Witek et al., "Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis", The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 297, no. 6, pp. G1093-G1106, 2009.
27. Y. Zhou, W. Dai, C. Lin et al., "Protective effects of necrostatin-1 against concanavalin A-induced acute hepatic injury in mice", Mediators of Inflammation, vol. 2013, Article ID 706156, 15 pages, 2013.
28. M. Shen, J. Lu, P. Cheng et al., "Ethyl pyruvate pretreatment attenuates concanavalin A-induced autoimmune hepatitis in mice", PLoS ONE, vol. 9, no. 2, Article ID e87977, 2014.
29. K. Chen, J. Li, J. Wang et al., "15-Deoxy-γ12,14-prostaglandin J2 reduces liver impairment in a model of Con A-induced acute hepatic inflammation by activation of PPARγ and reduction in NF-κB activity", PPAR Research, vol. 2014, Article ID 215631, 10 pages, 2014.
30. P. Cheng, W. Dai, F. Wang et al., "Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways", Biochemical and Biophysical Research Communications, vol. 443, no. 4, pp. 1162-1168, 2014.
31. +T cells", Journal of Immunology, vol. 184, no. 12, pp. 6585-6591, 2010.
32. D. S. El-Agamy, "Comparative effects of curcumin and resveratrol on aflatoxin B 1-induced liver injury in rats", Archives of Toxicology, vol. 84, no. 5, pp. 389-396, 2010.
33. L. Bujanda, M. García-Barcina, V. Gutiérrez-de Juan et al., "Effect of resveratrol on alcohol-induced mortality and liver lesions in mice", BMC Gastroenterology, vol. 6, article 35, 2006.
34. H. Ajamieh and N. C. Teoh, "Red wine coming up roses for intestinal ischemia reperfusion injury: role for resveratrol?" Journal of Gastroenterology and Hepatology, vol. 24, no. 11, pp. 1701-1709, 2009.
35. A. Kasdallah-Grissa, B. Mornagui, E. Aouani et al., "Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver", Life Sciences, vol. 80, no. 11, pp. 1033-1039, 2007.
36. L. Bujanda, E. Hijona, M. Larzabal et al., "Resveratrol inhibits nonalcoholic fatty liver disease in rats", BMC Gastroenterology, vol. 8, article 40, 2008.
37. C. D. Guy, A. Suzuki, M. Zdanowicz et al., "Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease", Hepatology, vol. 55, no. 6, pp. 1711-1721, 2012.
38. W. Mo, X. Xu, L. Xu et al., "Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell", Pancreatology, vol. 11, no. 6, pp. 601-609, 2012.
39. A. Omenetti, S. Choi, G. Michelotti, and A. M. Diehl, "Hedgehog signaling in the liver", Journal of Hepatology, vol. 54, no. 2, pp. 366-373, 2011.
40. J. E. Hooper and M. P. Scott, "Communicating with hedgehogs", Nature Reviews Molecular Cell Biology, vol. 6, no. 4, pp. 306-317, 2005.
41. M. Varjosalo, S.-P. Li, and J. Taipale, "Divergence of hedgehog signal transduction mechanism between Drosophila andmammals", Developmental Cell, vol. 10, no. 2, pp. 177-186, 2006.
42. Y. H. Feng, W. L. Zhou, Q. L. Wu, X. Y. Li, W.M. Zhao, and J. P. Zou, "Low dose of resveratrol enhanced immune response of mice", Acta Pharmacologica Sinica, vol. 23, no. 10, pp. 893-897, 2002.
43. H.-X. Wang, M. Liu, S.-Y. Weng et al., "Immunemechanisms of Concanavalin amodel of autoimmune hepatitis", World Journal of Gastroenterology, vol. 18, no. 2, pp. 119-125, 2012.
44. J. M. Austyn and S. Gordon, "F4/80, a monoclonal antibody directed specifically against the mouse macrophage", European Journal of Immunology, vol. 11, no. 10, pp. 805-815, 1981.
45. B. G. Lopez, M. S. Tsai, J. L. Baratta, K. J. Longmuir, and R. T. Robertson, "Characterization of Kupffer cells in livers of developing mice", Comparative Hepatology, vol. 10, article 2, 2011.
46. K. Bisht, K.-H. Wagner, and A. C. Bulmer, "Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds", Toxicology, vol. 278, no. 1, pp. 88-100, 2010.